高效和长效的分裂和混合蛋白质溶解以自组装的聚乳酸为目标,以自组装的聚乳酸为基础
Mei-Miao Zhan1, Hailing Chen2, Meiling He2
1Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, China.
Nature communications
|November 26, 2025
概括
新的分裂和混合蛋白质分解降解 (SM-PROTAC) 技术使用聚乳酸 (PLA) 改善药物特性. 基于PLA的SM-PROTACs表现出增强的瘤抑制和较低剂量的长期治疗潜力.
科学领域:
- 生物技术是生物技术.
- 药物运输 药物运输 药物运输
- 分子生物学分子生物学
背景情况:
- 蛋白质溶解向嵌合体 (PROTAC) 技术提供了一个"事件驱动"机制,但面临着高分子量,极性和低药性挑战.
- 现有的嵌合体分子需要优化,以提高生物可用性和循环时间.
研究的目的:
- 通过结合纳米技术和嵌合物技术来增强"嵌合物分子"的体内有效性.
- 开发一种新的"分割和混合"蛋白质分解降解 (SM-PROTAC) 策略,使用聚乳酸 (PLA) 作为自组装矩阵.
主要方法:
- 纳入聚乳酸 (PLA),FDA批准的生物医学材料,作为SM-PROTAC的自组装矩阵.
- 在细胞试验中对基于PLA的SM-PROTAC进行模型标降解的评估 (BRD4,ERα,CDK4).
- 在雌性小鼠中使用基于PLA的SM-PROTACs进行体内瘤抑制的评估.
主要成果:
- 基于PLA的SM-PROTAC在细胞试验中成功降解了模型目标.
- 在体内观察到基于PLA的SM-PROTACs显著抑制瘤.
- 这些PROTACs需要更低的基基含量 (对照组的约1/10) 并显示出长期的治疗潜力 (每三天注射一次).
结论:
- 基于PLA的SM-PROTAC表现出有前途的药物特性,克服了以前基于和脂质体的方法的局限性.
- 该战略在低剂量和长期应用方面提供了优势,增强了SM-PROTAC技术的制药潜力.
- 这项研究为纳米技术增强的 PROTACs 的应用提供了有价值的见解,以改善治疗结果.
相关概念视频
Overview Of Cell Separation And Isolation
Cell separation was first achieved in 1964 by S. H. Seal, who separated large tumor cells from the smaller blood cells using filtration. Two years later, Pohl and Hawk performed experiments on how cells respond differently to a nonuniform electric field based on the cell type. Such observations were the inception of cell separation methods, which allow isolating a single cell type from a heterogeneous sample.
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Organic Acids
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


